Emeritus Research Camberwell

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Obesity3 trials
• Asthma1 trial
• COPD1 trial
• Coronary artery disease1 trial
• Type 2 diabetes1 trial

Phase

• Phase 33 trials
• Early phase 11 trial
• Phase 1/21 trial
• Phase 21 trial

Status

• Recruiting3 trials
• Not yet recruiting2 trials
• Active, not recruiting1 trial

Lead sponsor

• Amgen2 trials
• Prana Therapies Inc2 trials
• Cyclarity Therapeutics, Inc.1 trial
• Pfizer1 trial

Running trials

• Recruiting

  A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or Obesity

  NCT07845500· Phase 3· Pfizer· Source

• Recruiting

  PRA-216 COPD Safety and Biomarker Study

  NCT07730281· Phase 2· Prana Therapies Inc· Source

  Contact: Sewa Rijal

• Recruiting

  Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

  NCT07684235· Phase 3· Amgen· Source

• Recruiting

  Study of PRA-216 in Healthy Participants and Participants With Mild-to-Moderate Asthma

  NCT07245368· Phase 1/2· Prana Therapies Inc· Source

  Contact: Sam Francis, MD

• Active, not recruiting

  Evaluation of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight

  NCT06858839· Phase 3· Amgen· Source

• Recruiting

  Placebo-controlled Study of Single and Multiple Ascending Doses of UDP-003 in Healthy Human Participants and Followed by an Open-label Patient Cohort

  NCT06813339· Early phase 1· Cyclarity Therapeutics, Inc.· Source

  Contact: Sewa Rijal, Dr

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Obesity2 recruiting
• Asthma1 recruiting
• COPD1 recruiting
• Coronary artery disease1 recruiting